Tag results:

pancreatic ductal adenocarcinoma

Reciprocal Regulation of LOXL2 and HIF1α Drives the Warburg Effect to Support Pancreatic Cancer Aggressiveness

[Cell Death & Disease] The authors identified that lysyl oxidase-like 2 was a hypoxia-responsive gene and is essential for the Warburg effect in PDAC.

Prognostic Role of Cell-Free DNA Biomarkers in Pancreatic Adenocarcinoma: A Systematic Review and Meta–Analysis

[Critical Reviews in Oncology Hematology] Cell-free DNA biomarkers indicate accelerated progression and decreased survival in PDAC.

Organoid Sensitivity Correlates with Therapeutic Response in Patients with Pancreatic Cancer

[Clinical Cancer Research] Prospectively generate patient derived organoids were established from a heterogeneous population of patients with pancreatic ductal adenocarcinoma (PDAC) including both basal and classical PDAC subtypes.

Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Limitations and Prospects: A Systematic Review

[Cell Communication and Signaling] Pancreatic ductal adenocarcinoma is not sensitive to monotherapy with immune checkpoint inhibitors, which might be related to the inhibitory immune microenvironment of pancreatic cancer.

Glycosylation of MUC6 by α1,4-Linked N-acetylglucosamine Enhances Suppression of Pancreatic Cancer Malignancy

[Cancer Science] Investigators ectopically expressed α1,4-N-acetylglucosaminyltransferase (α4GnT), the α1,4-linked N-acetylglucosamine biosynthetic enzyme, together with MUC6 in the human pancreatic cancer cell lines MIA PaCa-2 and PANC-1, neither of which expressed α4GnT and MUC6.

Modulation of Pancreatic Cancer Cell Sensitivity to FOLFIRINOX through microRNA-Mediated Regulation of DNA Damage

[Nature Communications] Scientists found that 41 and 84 microRNA inhibitors enhanced the sensitivity of Capan1 and MiaPaCa2 pancreatic ductal adenocarcinoma cells respectively.

Popular